Related Experiment Video
Updated: Apr 23, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer
Abstract:
MicroRNAs (miRNAs) are widely recognized as key players in cancer progression and drug resistance, but less is known about the role of miRNAs in triple-negative (estrogen receptor, progesterone receptor, and HER-2/neu) breast cancer (TNBC). The aim of the present study was to examine the expression profile of miRNAs and to explore their possible roles in TNBC. Differentially expressed miRNAs were identified by miRNA microarray and verified by quantitative real-time polymerase chain reaction. The expression of miR-93 was assessed by in situ hybridization in 119 cases of breast cancer. Cell proliferation potential was examined by MTT assay. Cell migration and invasion abilities were evaluated by a wound healing assay and transwell invasion or migration assay. Seven upregulated and ten downregulated miRNAs in TNBC were identified. The miR-93 expression level in TNBC tissues was significantly higher than that in non-triple-negative breast cancer tissues. The potentials of proliferation, invasion, and metastasis in breast cancer MCF-7 cells were promoted by ectopic transfection of miR-93. Our study found several distinct differentially expressed miRNAs in TNBC, as compared to non-triple-negative breast cancer. Among them, miR-93 may be considered as a biomarker associated with the biological and clinical characteristics of human TNBC.
Insights
MicroRNAs (miRNAs) play a role in triple-negative breast cancer (TNBC). Researchers identified distinct miRNA profiles in TNBC, with miR-93 potentially serving as a biomarker for this aggressive cancer subtype.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial in cancer development and treatment resistance.
- The specific role of miRNAs in triple-negative breast cancer (TNBC) remains underexplored.
- TNBC is an aggressive subtype lacking targeted therapies, necessitating biomarker discovery.
Purpose of the Study:
- To investigate the miRNA expression profile in TNBC.
- To identify specific miRNAs associated with TNBC characteristics.
- To explore the functional role of identified miRNAs in cancer progression.
Main Methods:
- miRNA microarray analysis to identify differentially expressed miRNAs.
- Quantitative real-time polymerase chain reaction (qRT-PCR) for verification.
- In situ hybridization to assess miR-93 expression in 119 breast cancer cases.
- Cell-based assays (MTT, wound healing, transwell) to evaluate proliferation, migration, and invasion.
Main Results:
- Seven miRNAs were upregulated, and ten were downregulated in TNBC compared to non-TNBC.
- miR-93 expression was significantly elevated in TNBC tissues.
- Ectopic miR-93 transfection enhanced proliferation, invasion, and metastasis in MCF-7 breast cancer cells.
Conclusions:
- Distinct miRNA expression patterns differentiate TNBC from other breast cancer subtypes.
- miR-93 shows potential as a biomarker for TNBC, correlating with biological and clinical features.
- Further research into miR-93's role could lead to novel therapeutic strategies for TNBC.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

